You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Comment on: Rifaximin in the Treatment of Irritable Bowel Syndrome. Is There a High Risk for Development of Antimicrobial Resistance?

Calanni, Fiorella DSc*; Renzulli, Cecilia PhD*; Fogli, Maria V. PhD; Barbanti, Miriam DSc*

Journal of Clinical Gastroenterology:
doi: 10.1097/MCG.0b013e3182951b6c
Letters to the Editor